Progression of genomic signatures in local and metastatic estrogen receptor-positive (ER plus ) breast cancer: Relevance to palliative treatment

被引：0
|
作者：
Symmans, William Fraser
Andreopoulou, Eleni
Booser, Daniel J.
Hatzis, Christos
Wallace, Michael J.
Zhang, Ya
Gong, Yun
Ignatiadis, Michail
Sotiriou, Christos
Andre, Fabrice
Peintinger, Florentina
Regitnig, Peter
Marth, Christian
Desmedt, Christine
Loi, Sherene
Moulder, Stacy L.
Hortobagyi, Gabriel N.
Pusztai, Lajos
Valero, Vicente
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Nuvera Biosci Inc, Woburn, MA USA
[3] Inst Jules Bordet, B-1000 Brussels, Belgium
[4] Inst Gustave Roussy, Villejuif, France
[5] Graz Univ, Graz, Austria
[6] Med Univ Innsbruck, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Acquired RBI mutations in estrogen receptor-positive (ER plus ) clinically advanced and metastatic breast cancer (MBC).
    McGregor, Kimberly
    Sokol, Ethan
    Danziger, Natalie
    Pavlick, Dean
    Elvin, Julia Andrea
    Vergilio, Jo-Anne
    Killian, Jonathan Keith
    Lin, Douglas I.
    Williams, Erik Abraham
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Hemmerich, Amanda
    Duncan, Daniel
    Huang, Richard
    Chung, Jon
    Reddy, Venkataprasanth P.
    Venstrom, Jeffrey
    Schrock, Alexa Betzig
    Alexander, Brian Michael
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [2] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2015, 20 (02) : 249 - 252
  • [3] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Iwase, Hirotaka
    ANNALS OF ONCOLOGY, 2017, 28 : 27 - 27
  • [4] Treatment strategy for metastatic breast cancer with estrogen receptor-positive tumor
    Hirotaka Iwase
    International Journal of Clinical Oncology, 2015, 20 : 249 - 252
  • [5] Elucidating the Mechanism of Action of Lenvatinib in Estrogen Receptor-Positive (ER plus ) Breast Cancer
    Gandasasmita, Natasha
    Vaidya, Gauri
    Datta, Arpita
    Marvalim, Charlie
    Lim, Joline Si Jing
    Lee, Soo Chin
    CANCER RESEARCH, 2024, 84 (08)
  • [6] Treatment of Estrogen Receptor-Positive Breast Cancer
    Lumachi, F.
    Brunello, A.
    Maruzzo, M.
    Basso, U.
    Basso, S. M. M.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (05) : 596 - 604
  • [7] Estrogen receptor-positive breast cancer: from genomic landscape to treatment approach
    De, Pradip
    Williams, Casey
    Krie, Amy
    Williams, Kirstin
    Klein, Jessica
    Carlson, Jennifer H.
    Dey, Nandini
    Leyland-Jones, Brian
    CANCER RESEARCH, 2016, 76
  • [8] Patterns of Progression in Hormone Receptor-Positive Metastatic Breast Cancer: An Argument for Local Therapy
    Rineer, J. M.
    Dvorak, T.
    Buchholz, D.
    Shah, N.
    Moroose, R.
    Kelly, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S275 - S275
  • [9] Recurrence Score (RS) and Treatment Decisions in Node-positive (N plus ), Estrogen Receptor-positive (ER plus ) Breast Cancer Patients in Israel
    Stemmer, S. M.
    Lieberman, N.
    Efrat, N.
    Geffen, D. B.
    Steiner, M.
    Soussan-Gutman, L.
    Merling, S.
    Rizel, S.
    Klang, S. H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S173 - S173
  • [10] Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer
    Goldberg, Jonathan
    Qiao, Na
    Guerriero, Jennifer L.
    Gross, Brett
    Meneksedag, Yagiz
    Lu, Yoshimi F.
    Philips, Anne V.
    Rahman, Tasnim
    Meric-Bernstam, Funda
    Roszik, Jason
    Chen, Ken
    Jeselsohn, Rinath
    Tolaney, Sara M.
    Peoples, George E.
    Alatrash, Gheath
    Mittendorf, Elizabeth A.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (02): : 496 - 504
12345